MEDACTA GROUP S.A. SF-,10

Research MEDACTA GROUP S.A. SF-,10 (6MD) on Bullrun: market cap EUR 2.77B, P/E 29.1, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker6MD
• ExchangeF
• CountrySwitzerland
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 2.77B
• P/E29.1
• Dividend yield0.9%
• Financial periodFY2025
• RevenueEUR 683.83M
• Revenue growth15.8%
• Net incomeEUR 95.46M
• Free cash flowEUR 9.55M
• Gross margin67.1%

Valuation Snapshot

latest market cap is EUR 2.77B; P/E is 29.1; dividend yield is 0.9%.

About MEDACTA GROUP S.A. SF-,10

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Frequently asked questions

What is MEDACTA GROUP S.A. SF-,10's market cap?

MEDACTA GROUP S.A. SF-,10's market capitalization is EUR 2.77B.

What is MEDACTA GROUP S.A. SF-,10's P/E ratio?

MEDACTA GROUP S.A. SF-,10's price-to-earnings (P/E) ratio is 29.1.

Does MEDACTA GROUP S.A. SF-,10 pay a dividend?

MEDACTA GROUP S.A. SF-,10 has a dividend yield of 0.9%.

What does MEDACTA GROUP S.A. SF-,10 do?

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa.